Pharmaceutical Grade 99% Piroxicam CAS 36322-90-4

China Pharmaceutical Grade 99% Piroxicam CAS 36322-90-4, Find details about China Piroxicam, Piroxicam Powder from Pharmaceutical Grade 99% Piroxicam CAS 36322-90-4

Model NO.
Piroxicam
Product Name
Piroxicam
CAS
36322-90-4
Molecular Fomula
C15h13n3o4s
Molecular Weight
331.35
Appearance
White Powder
Loss on Drying
Nmt 5%
Ash
Nmt 5%
Heavy Metals
Nmt 10ppm
Water
Nmt 5%
Boiling Point
634.1
Other Name
Piroxicam
Noq
1kg
Function
Anti-Inflammatory
Assay
99.0%
Shelf Life
2 Years
Trademark
Source Herb
Transport Package
1kg/Bag
Specification
25KG/Drum
Origin
China
Model NO.
Piroxicam
Product Name
Piroxicam
CAS
36322-90-4
Molecular Fomula
C15h13n3o4s
Molecular Weight
331.35
Appearance
White Powder
Loss on Drying
Nmt 5%
Ash
Nmt 5%
Heavy Metals
Nmt 10ppm
Water
Nmt 5%
Boiling Point
634.1
Other Name
Piroxicam
Noq
1kg
Function
Anti-Inflammatory
Assay
99.0%
Shelf Life
2 Years
Trademark
Source Herb
Transport Package
1kg/Bag
Specification
25KG/Drum
Origin
China

Pharmaceutical Grade 99% Piroxicam CAS 36322-90-4

Introduction
 

Product NamePiroxicam
Cas No.36322-90-4Delivery time7-10 days
EINECS  No.252-974-3Storagecool and dry place
AppearanceYellow crystalline powderMW331.35
Shelf  life2 yearsMFC15H13N3O4S

 


Application

Piroxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class used to relieve the symptoms of painful, inflammatory conditions like arthritis. Piroxicam works by preventing the production of a certain type of body chemical called prostaglandins which are involved in the mediation of pain, stiffness, tenderness and swelling. The medicine is available as capsules, tablets and (not in all countries) as a prescription-free gel 0.5%. It is also available in a betadex formulation, which allows a more rapid absorption of piroxicam from the digestive tract.

It was originally brought to market by Pfizer under the tradename Feldene in 1980, became generic in 1992, and is marketed worldwide under many brandnames.

It used in the treatment of rheumatoid and osteoarthritis, primary dysmenorrhoea, postoperative pain; and act as an analgesic, especially where there is an inflammatory component. The European Medicines Agency issued a review of its use in 2007 and recommended that its use be limited to the treatment of chronic inflammatory conditions, as it only in these circumstances that its risk-benefit ratio proves to be favourable.
Pharmaceutical Grade 99% Piroxicam CAS 36322-90-4


 


Pharmaceutical Grade 99% Piroxicam CAS 36322-90-4Pharmaceutical Grade 99% Piroxicam CAS 36322-90-4Pharmaceutical Grade 99% Piroxicam CAS 36322-90-4Pharmaceutical Grade 99% Piroxicam CAS 36322-90-4Pharmaceutical Grade 99% Piroxicam CAS 36322-90-4
Pharmaceutical Grade 99% Piroxicam CAS 36322-90-4
Pharmaceutical Grade 99% Piroxicam CAS 36322-90-4